Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lineage Cell Therapeutics (LCTX) Cash from Investing Activities (2016 - 2025)

Lineage Cell Therapeutics' Cash from Investing Activities history spans 16 years, with the latest figure at -$15.3 million for Q4 2025.

  • For Q4 2025, Cash from Investing Activities fell 681.94% year-over-year to -$15.3 million; the TTM value through Dec 2025 reached -$13.5 million, down 483.06%, while the annual FY2025 figure was -$13.5 million, 483.06% down from the prior year.
  • Cash from Investing Activities reached -$15.3 million in Q4 2025 per LCTX's latest filing, down from -$12000.0 in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $19.2 million in Q2 2023 to a low of -$40.9 million in Q3 2022.
  • Average Cash from Investing Activities over 5 years is -$286500.0, with a median of -$26000.0 recorded in 2024.
  • Peak YoY movement for Cash from Investing Activities: crashed 60067.65% in 2022, then soared 33634.78% in 2023.
  • A 5-year view of Cash from Investing Activities shows it stood at -$146000.0 in 2021, then crashed by 3394.52% to -$5.1 million in 2022, then soared by 290.94% to $9.7 million in 2023, then crashed by 72.95% to $2.6 million in 2024, then plummeted by 681.94% to -$15.3 million in 2025.
  • Per Business Quant, the three most recent readings for LCTX's Cash from Investing Activities are -$15.3 million (Q4 2025), -$12000.0 (Q3 2025), and -$14000.0 (Q2 2025).